Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer

By                

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1822-1826

Spandidos Publications

Access to resources Recommend Favorite

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

By Yardley Denise   Burris Howard   Peacock Nancy   Raefsky Eric   Melnik Marianne   Inhorn Roger   Shipley Dianna   Hainsworth John  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 471-475

Springer Publishing Company

Access to resources Recommend Favorite

Mesenchymal Stem Cells for Anti-Cancer Drug Delivery

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 310-318

Bentham Science Publishers

Access to resources Recommend Favorite

Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 3, 2011-03 ,pp. : 307-314

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1339-1352

Bentham Science Publishers

Access to resources Recommend Favorite